3623 results for «24»
3623 results
Structural heart disease intervention focusing on co-medical roles - Multidisciplinary approach in Japanese style
18 Feb 2023 – From PCR Tokyo Valves 2023
In this session, discover the intricacies of decision-making and a holistic strategy in structural heart disease intervention (in Japenese). Explore interdisciplinary collaboration and evaluate the adequacy of routine work through cases exploring TAVI, MitraClip, and LAAC.
TAVI and complex coronary artery anatomy
18 Feb 2023 – From PCR Tokyo Valves 2023
What defines 'complex TAVI and coronary artery scenarios'? Join this session to discover when chimney stenting for threatening left coronary artery obstruction becomes the ideal alternative, using balloon-assisted BASILICA for valve-in-valve TAVR, and addressing tissue embolisation post-TAVI.
Mutual understanding of essential roles of co-medical staff supporting structural heart disease intervention
18 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session in japanese to learn more about the essential roles of co-medicals in structural heart disease intervention: the decision-making regarding the treatment and imaging procedure, strategies and evaluating effects and complications.
Mitral valve interventions
18 Feb 2023 – From PCR Tokyo Valves 2023
Discover various compelling mitral valve interventions in this session: newer vs. older generations of the MitraClip devices, safety and feasibility of balloon mitral valvotomy, catheter ablation efficacy, and more!
Complication and bailout of TAVI
18 Feb 2023 – From PCR Tokyo Valves 2023
As TAVI is never risk-free, learn about bailout techniques to counter various complications. This session explores cases such as failure to release aortic stenosis after implantation of a self-expanding valve, retrieving a pigtail catheter straightener dropped into aorta and balloon rupture during TAVI.
Recorded case demonstration in TAVI and Mitral
17 Feb 2024 – From PCR Tokyo Valves 2024
This session of record case demonstrations aims to better understand daily clinical practice in TAVI and MitraClip, as well as helping to resolve daily clinical questions in structural heart disease interventions. [In Japanese]
TAV-in-TAV and coronary access
17 Feb 2024 – From PCR Tokyo Valves 2024
Learn about the challenges of coronary access during TAV-in-TAV procedure through this series of abstract submissions for PCR Tokyo Valves 2024. Expore the feasibility of redo TAVR in Sapien valves based on in-vivo CT assessment, examine the coaxiality of transcatheter aortic self-expanding valve, and more in...
Optimizing case selection and procedure guidance in transcatheter mitral valve interventions
02 Feb 2024 – From PCR Imaging Valves Madrid 2024
This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...
Multivalvular disease: mitral and aortic valve challenges explored
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore cutting-edge transcatheter valve interventions for mitral and aortic valve disorders, including valve-in-valve procedures and management strategies for paravalvular leakages, and learn about diagnosing and treating mitral annular calcification and transcatheter options in infective endocarditis.
Rapid-fire - Vascular access in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Discover a selection of rapid-fire TAVI vascular access cases: how to deliver a transcatheter heart valve in a calcified aorta, using the buddy wire technique in TAVR with severely tortuous aorta, and more!
Structural heart disease care: innovations, teamwork, and patient focus
17 Feb 2024 – From PCR Tokyo Valves 2024
Delivered in Japanese, this session highlights the latest advances in structural heart disease treatment and diagnostics. Learn to understand effective interprofessional collaboration and find out more about patient-centered care excellence!
A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients
22 May 2025 – From EuroPCR 2025
This session examines evolving catheterisation lab workflows, highlighting how integrated imaging, physiology, and procedural strategies are reshaping PCI practices. Speakers emphasize the importance of advanced pre-procedural planning using modalities such as intravascular ultrasound (IVUS) to optimise stent deployment, and cardiac computed tomography angiography (CCTA) to improve diagnosis...
A simple low profile solution to the pulmonary embolism problem: EKOS
21 May 2025 – From EuroPCR 2025
Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
Advanced imaging in structural heart disease interventions
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.
You'll also discover how AI-enabled device detection technology is being integrated into...
Advancing renal denervation in China: from guidelines to practice
20 May 2025 – From EuroPCR 2025
Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...
Advancing the standard of care in PCI with Bioadaptor: from simple to complex
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...
Troubleshooting in left main stenting: the role of imaging and physiology
20 May 2025 – From EuroPCR 2025
Expand your expertise on left main stenting by integrating intravascular imaging and physiology to improve outcomes. This session focuses on avoiding and managing stent deformation and optimal treatment of ostial left circumflex artery after crossover stenting, illustrated by clinical cases and expert commentary.
Align for the future with the Myval Octapro transcatheter heart valve series
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.
Clinical insights are backed by key data...
Broadening OPTIONs for LAA closure: innovations and outcomes
20 May 2025 – From EuroPCR 2025
Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...
